CagriSema Weight Loss Injection – Cagrilintide Diet Drug
CagriSema: A Novel Combination Therapy for Obesity CagriSema is a new weight loss injection from Novo Nordisk, the next step in the evolution of obesity treatments after Ozempic, Wegovy and Mounjaro. This combination therapy has cagrilintide, a long acting amylin analogue and semaglutide, a well known GLP-1 receptor agonist. Together they work synergistically to suppress …